Very excited that a Sepsis Seminar is part of the MM2025 pre-conference sessions #Sepsis2025 #WorldSepsisDay

I enjoy being an #InfectiousDiseases pharmacist because I am part of a multidisciplinary team and all the collaborative opportunities that are available. Happy #IDPharmacistsDay

To celebrate #IDPharmacistsDay look out for the videos from AdPha.au pharmacists showcasing their contributions to Innovations in Infectious Diseases @adphaau.bsky.social @nadinehillock.bsky.social @sonkoning.bsky.social @leggwamy.bsky.social @sidpharm.bsky.social

Very excited to be hearing about the ID innovations as ID pharmacists share their stories to celebrate #IDPharmacistsDay. We will be starting early from the ‘land down under’.

Surveillance of Gm negative resistance rates in Australia includes all organisms on the WHO list of priority pathogens, & good representation from across Australian states/territories - Jan Bell presenting at #Antimicrobials2025 #ASA2025 #GmNeg

Multiple challenges associated with AMR testing of Gm-negative bacteria - may result in over-reporting of resistance rates (e.g cefiderocol) potentially denying patients optimal treatment options, or under-reporting with life-threatening consequences - Prof Christian Giske #Antimicrobials2025 #AMR

@iainabbott.bsky.social #antimicrobials2025 Excellent summary slides of current and future oral antimicrobials for #UTIs and what’s lefts in the case of #MDR UTIs #IDSky #AMSsky

Advocating for linezolid TDM to improve patient outcomes 😊#Antimicrobials2025 #ASA2025 #linezolid #TDM @lisaparadiso.bsky.social

Highlighting undocumented off-label topical use of rifampicin during surgery in Australian hospitals, and opportunities for AMS #Antimicrobials2025 #ASA2025 #rifampicin #surgery #AntimicrobialStewardship @edraby.bsky.social #MattRawlins

Giske: beware using Cefiderocol discs in MBL strains - many isolates are S by MIC but in ATU (uncertain) on disc, resulting in over-calling of resistance. #antimicrobials2025

Dr Kylie McIntosh Safer Care Victoria providing updates on the Victorian pilot of pharmacist led UTI management, implications on #AMS and the critical need to #upskill #communitypharmacists #antimicrobials2025 #pharmacysymposium #IDsky #AMSsky #UTI

Urinary concentrations of antibiotics much more variable bt patients (compared to variability in blood conc). Many variables to consider including fluid intake, variability across a day, other urodynamic factors - Iain Abbott discussing complexity of treating MDR UTIs #Antimicrobials2025 #AMR #UTI

Kicking off the #pharmacysymposium We have @michyong.bsky.social highlighting the use of marabivir in tricky #ID populations #CMV and real world use beyond the clinical trials. (With promising clinical effectiveness) #antiviralstewardship #antimicrobials2025

@cindyclau.bsky.social #linezolid does one dose fit all???? Most likely not! Dr Cindy Lau goes through some scenarios - elderly, renal and hepatic impairment, #DDIs - where dose reductions may be warranted to improve patient care (& reduce toxicities) #antimicrobials2025 #IDsky #amssky

Prof Gabrielle Haeusler updating us on year in #AMSsky. Highlighting really important piece by the SNAPPY team on age inclusion in clinical trials. pubmed.ncbi.nlm.nih.gov/39158898/ #Antimicrobials2025

Combining NAUSP & NAPS datasets shows that in general restricted antibiotics have lower usage rates and higher appropriateness, but appropriateness of unrestricted antimicrobials should still be targets for AMS - Caroline Chen #Antimicrobials2025 @cazchen.bsky.social #surveillance #AMS

Jan Bell on the APAS data explorer. Looks amazing. shiny.safetyandquality.gov.au/APASDataExpl...

#ASA VP @iainabbott.bsky.social highlighting how to use OrgTRx data for 1 #antibiograms 2 susceptibility trends 3 extraction for patient level data #slicendice to meet your needs #antimicrobials2025 #ASA2025

Another amazing whirlwind talk from @erinmccreary.bsky.social on the new antifungals featuring Nora 🐶 #antimicrobials2025 #ASA

Utilizing cool technology to repackage an old drug @erinmccreary.bsky.social

@erinmccreary.bsky.social presenting on the new antifungal pipeline with novel patient experiences with them #antimicrobials2025 #IDsky #AMSsky #antifungals #mycology

Inappropriate and unregulated use of combination topical products containing antifungals, steroids and sub-therapeutic doses of antibiotics has resulted in spread of resistant strains of dermatophytes across Indian subcontinent - Dr Sarah Kidd #Antimicrobials2025 #AntifungalResistance #AMR

Have you seen the news?! 🥳 The long awaited cUTI guidelines are up for comments! 🤓📚 🔗: www.idsociety.org/practice-gui... Check it out & be sure to get your comments in by March 19, 2025 @ 5pm! #IDSky #PharmSky

Data Hoarders Are Rushing to Save Vanishing US Health Records -A grassroots effort to preserve US government data takes shape -Scientists work into the night to preserve CDC web information www.bloomberg.com/news/article... via @bloomberg.com @jasongale.bsky.social

Congratulations Kas Thursky and the NCAS team. A well deserved award

Another name change for Candida auris - “Candidozyma” belonging to the family “Metschnikowia” 😵‍💫😵‍💫😵‍💫 #antimicrobials2025 #ASA

The year in clinical microbiology prof Tony Korman giving us a #bluesky shout out and highlighting the exodus of X to Bluesky to stay up to date on #ID and #micro research & connect with other researchers 💙 #antimicrobials2025 #followus

In addition to the clinical advantages of switching from IV to oral antibiotics, there are huge savings in nursing time to gain, and therefore economic advantages, as well as engaging nurses in AMS - Nikhil Singh #antimicrobials2025 #ASA2025 #AMS #IVtoOralSwitch

The drivers of MRSA in remote Australia are linked directly with the social determinants of health and the ongoing impacts of colonisation #AMR #Antimicrobials2025

@ashabowen.bsky.social on her amazing work to reduce skin infections in indigenous communities. Preventative components strongly driven by community stakeholders. A masterclass in community engagement and values-based research.

Pharmacist Josephine Wen discussing the value of concise targeted auditing tools in conjunction with larger point prevalence audits for AMS programs. @ausantibiotics.bsky.social #ASA2025

Why is infectious diseases so fun? Because it’s complicated! - Dr Erin McCreary presenting on precision dosing of antimicrobials in complex patients #antimicrobials2025 #ASA2025

Aprox 1 in 2 aboriginal children living in remote Australian settings have impetigo, the highest prevalence in the world. Plus very high MRSA rates. Prof @ashabowen.bsky.social discussing the healthcare consequences of these issues #antimicrobials2025 #ASA2025 #MRSA #AboriginalAustralians #AMR

Next up … the NCAS session! #antimicrobials2025 #ASA2025